| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2000-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56958b534c2fdaf468e27a44997e28ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15d15288f43adf7a84d9257ca971597f |
| publicationDate |
2001-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-10025308-A1 |
| titleOfInvention |
Combination of cerivastatin with ACE inhibitors and their use in medicinal products |
| abstract |
The invention relates to a combination of at least one ACE inhibitor (component A) with the HMG-CoA reductase inhibitor cerivastatin (component B), the use of this combination for the prophylaxis and control of diseases, in particular cardiovascular diseases, medicaments containing this combination and their manufacture. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004080488-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004080488-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03092729-A1 |
| priorityDate |
2000-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |